MEN1 and digestive system neuroendocrine tumor, grade 1/2: Between 20% and 40% of gastroenteropancreatic neuroendocrine tumors (GEP-NET) are associated with inactivating mutations in the multiple endocrine neoplasia I (MEN1) gene encoding the tumor suppressor protein menin (1–3).